EGFRs | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,738 results for “EGFRs”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC

100 participants · First posted Dec 9, 2016

Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II

40 participants · First posted Jan 8, 2024

Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)

896 participants · First posted Jul 24, 2019

Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients

63 participants · First posted Dec 26, 2017

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

492 participants · First posted Jan 14, 2019

Active, not recruiting

INHERIT EGFR - Studying Germline EGFR Mutations

121 participants · First posted Dec 21, 2012

Not yet recruiting

Vebreltinib Plus PLB1004 Versus Platinum-based Doublet Chemotherapy in Patients With EGFRm, MET+, Locally Advanced or Metastatic NSCLC Following EGFR-TKI Failure

278 participants · First posted May 14, 2025

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

23 participants · First posted Jun 28, 2024

Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC

10 participants · First posted Feb 3, 2015

EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

601 participants · First posted Mar 21, 2016

Page 1 of 136